for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Vbl Therapeutics To Present New Data On Its MOSPD2 Bispecific Antibody Program For Solid Tumors

May 18 (Reuters) - Vascular Biogenics Ltd:

* VBL THERAPEUTICS TO PRESENT NEW DATA ON ITS MOSPD2 BISPECIFIC ANTIBODY PROGRAM FOR SOLID TUMORS IN LATE BREAKING RESEARCH SESSION OF THE AACR VIRTUAL ANNUAL MEETING Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up